Clinical trial
Pilot Study of Raptiva to Treat Sjogren's Syndrome
NCT00344448 · National Institute of Dental and Craniofacial Research (NIDCR), NIH · Terminated
Key facts
| NCT number | NCT00344448 |
|---|---|
| Title | Pilot Study of Raptiva to Treat Sjogren's Syndrome |
| Official title | A Randomized, Placebo Controlled, Proof of Concept, Study of Raptiva, a Humanized Anti-CD-11a Monoclonal Antibody, in Patients With Sjogren's Syndrome |
| Lead sponsor | National Institute of Dental and Craniofacial Research (NIDCR), NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sjogren's Syndrome |
| Intervention type | Drug |
| Interventions | Raptiva |
| Enrollment | 10 |
| Start date | Jun 1, 2006 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Jun 26, 2006 |
| Last update posted | Dec 21, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: